Detection of cytomegalovirus DNA in colorectal tissue from Swedish and Vietnamese patients with colorectal cancer

Anticancer Research

Volumn 33, Issue 11, 2013, Pages 4947-4950

  Dimberg, Jan ^a   Trinh Hong, Thai ^b   Skarstedt, Marita ^c   Löfgren, Sture ^c   Zar, Niklas ^c   Matussek, Andreas ^c  

^a JÖNKÖPING UNIVERSITY   (Sweden)

^b VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

^c RYHOV COUNTY HOSPITAL   (Sweden)

Author keywords

Colorectal cancer; Cytomegalovirus; Swedish; Vietnamese; Viral DNA

Indexed keywords

HUMAN CYTOMEGALOVIRUS DNA; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER TISSUE; COLORECTAL CANCER; DISEASE ASSOCIATION; DISSEMINATED CANCER; DNA DETERMINATION; ETHNIC DIFFERENCE; FEMALE; HUMAN; HUMAN CYTOMEGALOVIRUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SWEDEN; VERY ELDERLY; VIET NAM; VIRUS CARCINOGENESIS;

COLORECTAL CANCER; CYTOMEGALOVIRUS; SWEDISH; VIETNAMESE; VIRAL DNA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; SWEDEN; VIETNAM; VIRAL LOAD;

EID: 84891352784     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Landolfo S, Gariglio M, Gribaudo G and Lembo D: The human cytomegalovirus. Pharmacol Ther 98: 269-297, 2003.
2. Dowd JB, Aiello AE: Socioeconomic differentials in immune response. Epidemiology 20: 902-908, 2009.
3. Gaytant MA, Galama JM, Semmekrot BA, Melchers WJ, Sporken JM, Oosterbaan HP, van Dop PA, Huisman A, Merkus HM and Steegers E: The incidence of congenital cytomegalovirus infections in the Netherlands. J Med Virol 76: 71-75, 2005.
4. Cannon MJ, Schmid DS and Hyde TB: Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 20: 202-213, 2010.
5. Chen MH, Chen PC, Jeng SF, Hsieh CJ, Su FC, Liao HF, Su YN, Lin SJ and Hsieh WS: High perinatal seroprevalence of cytomegalovirus in northern Taiwan. J Paediatr Child Health 44: 166-169, 2008.
6. Ahlfors K: IgG antibodies to cytomegalovirus in a normal urban Swedish population. Scand J Infect Dis 16: 335-337, 1984.
7. Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson BO and Ferguson FG: Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: The Swedish longitudinal OCTO immune study. Mech Ageing Dev 121: 187-201, 2000.
8. Cinatl J, Scholz M, Kotchetkov R, Vogel JU and Doerr HW: Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology. Trends Mol Med 10: 19-23, 2004.
9. Michaelis M, Doerr HW and Cinatl J: The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 11: 1-9, 2009.
10. Knösel T, Schewe C, Dietel M and Petersen I: Cytomegalovirus is not associated with progression and metastasis of colorectal cancer. Cancer Lett 211: 243-247, 2004.
11. Mariguela VC, Chacha SG, Cunha Ade A, Troncon LE, Zucoloto S and Figueiredo LT: Cytomegalovirus in colorectal cancer and idiopathic ulcerative colitis. Rev Inst Med Trop Sao Paulo 50: 83-87, 2008.
12. Akintola-Ogunremi O, Luo Q, He TC and Wang HL: Is cytomegalovirus associated with human colorectal tumorigenesis? Am J Clin Pathol 123: 244-249, 2005.
13. Bender C, Zipeto D, Bidoia C, Costantini S, Zamo A, Menestrina F and Bertazzoni U: Analysis of colorectal cancer for human cytomegalovirus presence. Infect Agent Cancer 16: 1-6, 2009.
14. Collins D, Hogan AM and Winter DC: Microbial and viral pathogens in colorectal cancer. Lancet Oncol 12: 504-512, 2011.
15. Magrisso IJ, Richmond RE, Carter JH, Pross CB, Gilfillen RA and Carter HW: Immunohistochemical detection of RAS, JUN, FOS and P53 oncoprotein expression in human colorectal adenomas and carcinomas. Lab Invest 69: 674-681, 1993.
16. Al-Sohaily S, Biankin A, Leong R, Kohonen-Corish M and Warusavitarne J: Molecular pathways in colorectal cancer. J Gastroenterol Hepatol 27: 1423-1431, 2012.
17. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW: Identification of c-myc as a target of the APC pathway. Science 281: 1509-1512, 1998.
18. Markowitz SD and Bertagnolli MM: Molecular origins of cancer: Molecular basis of colorectal cancer. N Eng J Med 361: 2449-2460, 2009.
19. Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI and Cobbs CS: Specific localisation of human cytomegalovirus nucleic acid and proteins in human colorectal cancer. Lancet 360: 1557-1563, 2002.
20. Michaelis M, Kotchetkov R, Vogel JU, Doerr HW and Cinatl J Jr.: Cytomegalovirus infection blocks apoptosis in cancer cells. Cell Mol Life Sci 61: 1307-1316, 2004.
21. Cano P, Han FS, Wang HL, Fernandez-Vina M and Han XY: Cytokine gene polymorphisms affect reactivation of cytomegalovirus in patients with cancer. Cytokine 60: 417-422, 2012.
22. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC cancer staging manual. 7th ed. NewYork, Springer, 2010.
23. Chen HP, Jiang JK, Chen CY, Chou TY, Chang T, Lin SF, Chan CH, Yang CY, Lir CH, Cho L and Cha YJ: Human cytomegalovirus preferentially infects the neoplastic epithelium of colorectal cancer: A quantitative and histological analysis. J Clin Virol 54: 240-244, 2012.
24. Balkwill F: Chemokine biology in cancer. Semin Immunol 15: 49-55, 2003.
25. Strieter RM, Burdick MD, Mestas J, Gomperts BN, Keane MP and Belperio JA: Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 42: 768-778, 2006.
26. Dimberg J, Dienus O, Löfgren S, Hugander A and Wågsäter D: Expression and gene polymorphisms of the chemokine CXCL5 in colorectal cancer patients. Int J Oncol 31: 97-102, 2007.
27. Terzic J, Grivennikov S, Karin E, Karin M: Inflammation and colon cancer. Gastroenterology 138: 2101-2114, 2010.
28. Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR and Issa JPJ: MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 97: 1330-1338, 2005.
29. Paschos K and Allday MJ: Epigenetic reprogramming of host genes in viral and microbial pathogenesis. Trends Microbiol 18: 439-447, 2010.
30. Dimberg J, Trinh Hong T, Skarstedt, Löfgren S, Zar N and Matussek A: Analysis of APC and IGFBP7 promoter gene methylation in Swedish and Vietnamese colorectal cancer patients. Oncol Lett 5: 25-30, 2013.